BioAtla (BCAB) Free Cash Flow (2020 - 2026)

BioAtla's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$5.3 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 67.66% year-over-year to -$5.3 million in Q1 2026; TTM through Mar 2026 was -$37.2 million, a 35.22% increase from a year earlier, with the FY2025 full-year figure at -$48.2 million, up 32.99% from the prior year.
• Free Cash Flow advanced to -$5.3 million in Q1 2026 per BCAB's latest filing, from -$7.9 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$5.1 million in Q3 2024 and bottomed at -$30.8 million in Q1 2024.
• The 5-year median for Free Cash Flow is -$19.2 million (2024), against an average of -$18.8 million.
• Across the five-year window, Free Cash Flow soared 81.25% in 2024 and plunged 92.54% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$24.6 million in 2022, then slipped by 21.6% to -$29.9 million in 2023, then surged by 43.93% to -$16.8 million in 2024, then surged by 52.84% to -$7.9 million in 2025, then jumped by 33.46% to -$5.3 million in 2026.
• Per Business Quant, the three latest BCAB Free Cash Flow figures stand at -$5.3 million (Q1 2026), -$7.9 million (Q4 2025), and -$9.9 million (Q3 2025).